Elongation of very long chain fatty acids protein 3 (UniProt: Q9HB03; also known as EC:18.104.22.168, 3-keto acyl-CoA synthase ELOVL3, Cold-inducible glycoprotein of 30 kDa, ELOVL fatty acid elongase 3, ELOVL FA elongase 3, Very long chain 3-ketoacyl-CoA synthase 3, Very long chain 3-oxoacyl-CoA synthase 3) is encoded by the ELOVL3 (also known as CIG30) gene (Gene ID: 83401) in human. ELOVL3 is a multi-pass membrane protein of endoplasmic reticulum (ER). It catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. Its C-terminal di-lysine motif (aa 266-270) confers endoplasmic reticulum localization. This ER-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. It exhibits higher activity towards C18:0 acyl-CoAs. It is strongly expressed in normal skin, breast, colon, liver tissues. A decrease in the expression of ELOVL3 is reported in colorectal tumors compared to normal colorectal epithelium. ELOVL3 is reported to be involved in the regulation of the progression of adipogenesis through activation of peroxisome proliferator-activated receptor (PPAR) in mouse adipocytic 3T3-L1 cells. Its levels are elevated more than200-fold in cold-stressed animals. (Ref.: Alnabulsi, A., et al. (2019). Int. J. Cancer. 145(4);1138-1147; Kobayashi, T., and Fujimori, K. (2012). 302(12); E1461-E1471; Westerberg, R., et al. (2006). J. Biol. Chem. 281(8); 4958-4968).
Clone V61 P2B3 D10 is a mouse monoclonal antibody that detects Elongation of very long chain fatty acids protein 3 (ELOVL3). It targets and epitope within 9 amino acids from the N-terminal region.
Ovalbumin-conjugated linear peptide corresponding to 9 amino acids from the N-terminal region of human Elongation of very long chain fatty acids protein 3 (ELOVL3).
Quality Control Testing
Evaluated by Immunohistochemistry (Paraffin) in human colon cancer tissue sections.
Immunohistochemistry (Paraffin) Analysis: A 1:250 dilution of this antibody detected ELOVL3 in human colon cancer tissue sections.
Western Blotting Analysis: A representative lot detected ELOVL3 in Western Blotting applications (Alnabulsi, A., et al. (2019). Int J Cancer. 45(4):1138-1147).
ELISA Analysis: A representative lot detected ELOVL3 in ELISA applications (Alnabulsi, A., et al. (2019). Int J Cancer. 145(4):1138-1147).
Immunohistochemistry Applications: A representative lot detected ELOVL3 in Immunohistochemistry applications (Alnabulsi, A., et al. (2019). Int J Cancer. 145(4):1138-1147).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-ELOVL3, clone V61 P2B3 D10, Cat. No. MABS2226, is a mouse monoclonal antibody that detects ELOVL3 and is tested for use in ELISA, Immunohistochemistry (Paraffin), and Western Blotting.
Purified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Storage and Stability
Recommended storage: +2°C to +8°C.
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.